期刊文献+

慢性肝病与相关细胞因子水平的研究 被引量:4

Study on the changes of serum IL-6,IL-8,IL-10 and TNF-α levels in patients with chronic hepatic diseases
下载PDF
导出
摘要 目的探讨慢性肝病患者血清白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)和肿瘤坏死因子(TNF-α)在肝病发展过程中的含量变化及相互关系。方法用放射免疫分析检测105例慢性肝病患者和32例正常对照组血清IL-6、IL-8、IL-10、TNF-α的水平。结果各组慢性肝病患者血清IL-6、IL-8、TNF-α含量高于正常对照组,有统计学意义(P<0.05);IL-10低于正常对照组,有统计学意义(P<0.01);各项指标以肝硬化患者最为显著;肝病患者各组间细胞因子水平差异有统计学意义(P<0.01)。IL-6、IL-8、IL-10、TNF-α水平的变化与肝病病变程度密切相关。结论细胞因子IL-6、IL-8、IL-10和TNF-α在肝病发展过程中相互作用,联合检测其水平的变化对探讨慢性肝病的诊断、治疗和预后具有重要意义。 Objective To investigate the changes of serum IL-6,IL-8,IL-10 and TNF-α levels in patients with chronic hepatic diseases of various types and stages. Methods Serum IL-6,IL-8,IL-10 and TNF-α levels were measured with RIA in 105 patients with chronic hepatic diseases and 32 controls. Results Serum levels IL-6, IL-8 and TNF-α were significantly higher in patients with chronic hepatic diseases than those in controls(P〈0.05), but serum IL-10 levels were significantly lower in the patients (P〈0. 01 ), especially for those patients with liver cirrhosis. There were significantly differences of these cytokines levels among the different types of patients. Serum IL-6,IL-8, and TNF-α levels were positively correlated with the degrees of pathological changes of hepatic disease, but serum IL- 10 levels were negative correlation. Conclusion These cytokines participate in the pathogenesis of chronic hepatic disease. Combined measurements of their serum levels may be of important value for the diagnosis, treatment and outcome prediction of the disease.
出处 《检验医学与临床》 CAS 2006年第1期3-4,共2页 Laboratory Medicine and Clinic
关键词 慢性肝病 细胞因子 IL-6 IL-8 IL-10 TNF—α Chronic hepatic disease Cytokine Interleukin 6(IL-6) Interleukin-8(IL-8) Interleukin-10(IL-10) Tumor necrosis factor-α(TNF-α)
  • 相关文献

参考文献5

二级参考文献3

共引文献75

同被引文献38

  • 1井申荣,邹全明.白细胞介素10的研究进展[J].免疫学杂志,2006,22(z1):26-28. 被引量:16
  • 2王吉耀.重视肝纤维化的基础与临床研究[J].中华医学杂志,2005,85(15):1009-1010. 被引量:23
  • 3吴鹏,郭建华,朱名安,周有利,孙竞.肝硬化患者血清NO、NOS、IL-6和IL-8含量分析[J].郧阳医学院学报,2005,24(4):232-233. 被引量:2
  • 4申保生,高海丽,宋新文.复方甘草酸苷对慢性乙型肝炎患者血清肿瘤坏死因子-α、白细胞介素-6的影响[J].中国药房,2006,17(21):1646-1647. 被引量:22
  • 5Kaido T, Oe H, Imamora M. Interleukin-6 angments hepatocyte growth factor-induced liver regeneration; involvement of STAT3 ac- tivation[J]. Hepatogastroenterology, 2004,51 (60) : 1 667-1 670.
  • 6Kuriyama S, okoyama F, Inoue H, et al. Sequential assessment of the intrahepatic expression of epidermal growth factor and transform- ing growth factor-betal in hepatofibrogenesis of a rat cirrhosis model [J]. Int J Mol Med, 2007,19(2) : 317-324.
  • 7曾令兰,罗瑞德,李淑莉,等.日本血吸虫感染小鼠肝脏IL-2、TNF-a的表达及注射该因子后对肝纤维化的影响[J].中华寄生虫学与寄生虫病杂志,2003,21(3):150-153.
  • 8Veldt BJ, 14ansen BE, Ikeda K, et al. Loug-erm clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patient s with non-response or relapse to interferon[J] . Scand J Gast roenterol, 2006,41(9) : 1 087-1 094.
  • 9Orlent H, Hansen BE, Willems M, et 81. Biochemical and histolog- ical effect s of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial[J]. J Hepatol, 2006,45 (4) :539-546.
  • 10KAIDO T,OE H,IMAMORA M.Interleukin-6 angments hepato-cyte growth factor-induced liver regeneration;involvement ofSTAT3 activation. Hepato Gastroenterology . 2004

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部